Rare variant testing across methods and thresholds using the multi-kernel sequence kernel association test (MK-SKAT) by Urrutia, Eugene et al.
Rare variant testing across methods and thresholds using the 
multi-kernel sequence kernel association test (MK-SKAT)
Eugene Urrutia,
Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 
27599, USA
Seunggeun Lee,
Department of Biostatistics, University of Michigan, Ann Arbor, MI 48105, USA
Arnab Maity,
Department of Statistics, North Carolina State University, 2311 Stinson Drive, Raleigh, NC 27695, 
USA
Ni Zhao,
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave 
N, Seattle, WA 98109, USA
Judong Shen,
Quantitative Sciences, R&D, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 
27709, USA
Yun Li, and
Department of Genetics and Department of Biostatistics, The University of North Carolina at 
Chapel Hill, Chapel Hill, NC 27599, USA
Michael C. Wu
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave 
N, Seattle, WA 98109, USA
Eugene Urrutia: gene.urrutia@gmail.com; Seunggeun Lee: leeshawn@umich.edu; Arnab Maity: arnab_maity@ncsu.edu; 
Ni Zhao: nzhao@fhcrc.org; Judong Shen: judong.x.shen@gsk.com; Yun Li: yunli@med.unc.edu; Michael C. Wu: 
mcwu@fhcrc.org
Abstract
Analysis of rare genetic variants has focused on region-based analysis wherein a subset of the 
variants within a genomic region is tested for association with a complex trait. Two important 
practical challenges have emerged. First, it is difficult to choose which test to use. Second, it is 
unclear which group of variants within a region should be tested. Both depend on the unknown 
true state of nature. Therefore, we develop the Multi-Kernel SKAT (MK-SKAT) which tests 
across a range of rare variant tests and groupings. Specifically, we demonstrate that several 
popular rare variant tests are special cases of the sequence kernel association test which compares 
pair-wise similarity in trait value to similarity in the rare variant genotypes between subjects as 
measured through a kernel function. Choosing a particular test is equivalent to choosing a kernel. 
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Similarly, choosing which group of variants to test also reduces to choosing a kernel. Thus, MK-
SKAT uses perturbation to test across a range of kernels. Simulations and real data analyses show 
that our framework controls type I error while maintaining high power across settings: MK-SKAT 
loses power when compared to the kernel for a particular scenario but has much greater power 
than poor choices.
Keywords and phrases
Rare variants; Perturbation; Sequence kernel association test; Sequencing association studies
1. INTRODUCTION
Identification of genetic variants influencing complex phenotypes and disease is a major 
goal of modern human genetics research. So far, despite the success of genome wide 
association studies (GWAS) [9], newly discovered trait-associated genetic variants still fail 
to explain a large proportion of the heritability of complex traits [6]. It is hoped that with the 
advent of accessible DNA sequencing technology [18, 17, 2], investigators can uncover 
more of the socalled missing heritability. Some of the added information contained in 
sequencing data includes rare variants, that is variants with minor alleles whose population 
frequency is low. This contrasts with microarray technology which typically focuses on 
common variants that have relatively high minor allele frequency (MAF). Rare variants 
associated with disease have already been reported [4, 25, 22]. However, important 
distinctions between the analysis of common variants and rare variants must be made [3]. 
Most importantly, the standard analysis of common variants focuses on analysis of each 
individual variant, one-by-one. Yet, power decreases with lower MAF such that standard 
approaches for common variants are vastly underpowered for analysis of rare variants. Also, 
multiple comparison corrections are a concern since the number of variants is dramatically 
larger.
To address the limitations of using standard analytical approaches for variants, investigators 
have turned to region based approaches for rare variant association testing. In this class of 
approaches, multiple genetic variants within a region, typically a biologically meaningful 
unit such as a single gene or an exon, are simultaneously considered together. The 
cumulative effect of the entire group of variants, or more often a subgroup of the variants 
(e.g. those with MAF <1%), is assessed for association with the phenotype. Grouping the 
variants and testing only the cumulative effect allows aggregation of effects across several 
variants. It also addresses the multiple comparison correction concern by substantially 
decreasing the number of tests performed. A wide range of methods have been developed 
with varying characteristics and underlying principles [19, 13, 20, 16, 21, 27].
Despite the success of current approaches for rare variant testing [4, 25, 22], a number of 
practical concerns have arisen. In particular, given the wide range of testing approaches 
which are optimized toward different scenarios, it is unclear which method to use for any 
particular data set. Furthermore, it is unclear which strategy to use for grouping variants, e.g. 
grouping variants with MAF <3% vs <1%, within a region. Unfortunately, the answer to 
both questions depends on the underlying true state of nature which is unknown prior to 
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analysis. Knowledge on this would preclude need for analysis. Selecting the “best” (often 
most significant) result after conducting analyses using multiple methods or multiple group 
strategies would lead to severely inflated type I error and increased false positives. Although 
some recent work has been done on omnibus testing across different grouping strategies [23, 
14] or across different testing approaches [12], few methods consider both the testing 
approach and the grouping strategy simultaneously.
To address this problem, we propose the multi-kernel sequence kernel association test (MK-
SKAT). In this article, we show that many commonly used testing approaches are equivalent 
to particular cases of the sequence kernel association test (SKAT). SKAT is a similiarity 
based analysis approach for rare variant testing wherein pair-wise similarity between 
individuals based on their rare variant profiles is measured via a kernel function and then 
compared to pairwise similarity in phenotype. Specifically, the currently used methods are 
equivalent to versions of SKAT using different kernel functions. We further show that 
different choices of grouping strategies are also equivalent to using the SKAT with different 
kernel functions. Consequently, the question of selecting a test to use as well as selecting a 
grouping strategy reduces to the problem of selecting an appropriate kernel function. This 
equivalence then leads us to exploit perturbation based procedures for omnibus testing 
across multiple kernels (and accordingly multiple grouping and rare variant testing 
approaches) [26]. We conduct simulations and a real data application to validate our 
approach and show that our proposed method loses a small amount of power when 
compared to the optimal grouping and testing approach, but offers considerably more power 
over poor choices.
Broadly speaking, the main contribution of this work is to address a practical problem faced 
by applied statistical researchers interested in analyzing sequencing association studies. In 
addition, we explicitly draw the connections between SKAT and several other rare variant 
tests and grouping strategies which then enables utility of our previously developed 
perturbation testing framework [26]. Although the perturbation framework underlies the 
statistical mechanisms for generating a p-value, we emphasize that the current project differs 
significantly from our previous work in terms of the overall objective and the application to 
rare variants. Furthermore, to accommodate features specific to rare variant sequencing 
studies, i.e. larger number of kernels (corresponding to different tests and grouping 
strategies) as well as the larger number of variants which are not highly correlated, we also 
make some technical modifications to the perturbation procedure to improve computation.
The remainder of this paper is organized as follows. In the next section, we first review the 
generic SKAT method and describe how different testing approaches and different 
groupings all correspond to SKAT under different kernels. We then present the proposed 
MK-SKAT approach for testing across different tests and groupings. We show results from 
some representative simulation studies and from real data to illustrate our approach. We 
conclude with a brief discussion.
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Within this article, we describe our methodology within the context of analyzing a single 
gene region. However, the approach can be applied to multiple regions separately, with 
appropriate control for multiple comparisons. We let yi denote the phenotype for the ith 
individual in the study (i = 1, …, n), and Xi be a vector of environmental or demographic 
variables for which we would like to adjust. For dichotomous phenotypes we let yi = 0 or 1 
for controls and cases, respectively. For each given region, we let Zi be the vector of genetic 
variants within the region coded under the additive model. The objective is to test for an 
association between y and all the variants in Z or a subset of the variants in Z while 
adjusting for X. We let  denote the indices of the variants within Z that we would like to 
test. For instance  may be the indices of the variants with MAF < 1% or the 
nonsynonymous variants. In doing so, one may select a subset of the variants in the region to 
test or one may test all of the variants within the region. Clearly, restricting attention to the 
truly causal variants would result in the highest power; however, which variants are causal is 
unknown. At the same time, there are a range of tests to choose from. Determining which 
group of variants to test and which test to use poses a grand challenge for geneticists.
In this section, we first review the SKAT method and draw connections between SKAT and 
several other important tests. We describe how the questions of which test to use and which 
variants to test can be recast as a question of kernel choice. We then develop the MK-SKAT 
to construct an omnibus test that simultaneously considers multiple tests and grouping 
strategies.
2.1 Connections between SKAT and other methods
2.1.1 SKAT—SKAT is a similarity based test that operates by comparing pair-wise 
genotypic similarity between individuals to pair-wise phenotypic similarity, with correlation 
suggestive of association. Mathematically, SKAT uses the linear model for quantitative 
traits
and the logistic model for case/control studies
where α0 is an intercept term, α is the vector of regression coefficients for the covariates, 
and εi has mean zero and variance σ2. The variants of interest Z i for the i-th individual are 
related to the outcome only through the function h(·) which is a general function lying in a 
functional space generated by a positive definite kernel function K(·, ·). Intuitively, K(Z i, 
Z i′) measures similarity between i-th and i′-th individuals in the study based on Z , the 
variants of interest. This function fully specifies the relationship between the variants and 
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the outcome. If one sets , which is the linear kernel, then this implies 
that the function h(Z i) = Σj∈  βjZij, i.e. h(·) is linear and the outcome depends on the 
variants in a linear manner. By specifying a different kernel, one may specify an alternative 
model. Under the default SKAT parameters,  where wj is 
equal to the beta probability density function with parameters 1 and 25 evaluated at the 
MAF for the j-th variant. Also by default,  is set to be the entire group of both common and 
rare variants within a region. This corresponds to a linear model but with additional up-
weighting for the effect of rarer variants.
To test the effect of the rare variants under SKAT corresponds to testing H0 : h(Z ) = 0. 
Defining the kernel matrix, K, to be the n-by-n matrix with i, i′-th term equal to K(Z i, 
Z i′), for quantitative traits, we construct the variance component score statistic
where ŷ = α̂0 + Xα̂ with α̂0, α̂, and σ̂ estimated under H0. For dichotomous traits, we can 
construct a similar score statistic
where ŷ = logit−1(α̂0 +Xα̂) and α̂0, α̂ are again estimated under H0. To obtain a p-value for 
significance, asymptotically,  is a mixture of chi-squared distributions, with 
weights λj equal to the eigenvalues of  where P0 = D − DX(X′DX)−1X′D with D 
= I for quantitative traits and D = diag{ŷi(1 − ŷi)} for dichotomous traits. This null 
distribution can be approximated using moment matching approaches [15] or exact methods 
[5].
2.1.2 Existing methods and grouping strategies as special cases of the SKAT
—A wide range of region-based analysis approaches of rare variants have been proposed. 
Generally, however, they tend to fall within two classes: burden-based approaches and 
similarity-based approaches. Burden-based tests generally operate by collapsing the rare 
variants within a region into a single value using (possibly weighted) averaging and then 
testing for association by regressing the phenotype on the collapsed variable or applying 
appropriate permutation-based approaches. Letting  denote the indices of the rare variants 
over which we would like to collapse, then the cohort allelic sum test (CAST) and combined 
multivariate collapsing (CMC) collapses the genetic variants within a region to a single 
binary variable
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which is an indicator for whether the ith individual has any rare variants within the region. In 
a slight variation, the count-based collapsing method computes the collapsed variable as
which is the total number of rare variants within the region. To place a higher weight on 
variants which are rarer, the weighted count collapsing method collapses the variants in 
into
where wj is a weight for the jth variant which is inversely related to the MAF for the jth 
variant. To test whether the rare variants are related to the phenotype, the outcome is 
regressed on the collapsed variable and possible covariates using the models
or
for quantitative and dichotomous traits, respectively. Testing for the rare variant effect then 
corresponds to testing H0 : βC = 0 which can be done using a standard 1-df test. The burden-
based rare variant association tests are similar in that they sum over all of the rare variant 
genetic information. Thus, they are most powerful when the effects of the variants are truly 
associated with the outcome and with common direction of effect, that is, all variants are 
deleterious or all variants are protective. Power is lost when effects are opposite in directions 
or non-causal variants are included in .
Similarity-based tests were proposed to address the power loss due to variants with opposing 
effects. This class includes SKAT, and compares pair-wise similarity between individuals in 
terms of their genotype values to pair-wise similarity in phenotype, with correlation 
suggestive of association. Also included within this class is the C-alpha test which tests for 
an over-dispersion of the variance resulting from a rare variant effect rather than a change in 
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the mean effect. By testing variance rather than net effect, the test is powerful to detect 
genetic association when the effects of the variants are not all in the same direction.
It has been previously noted that individual tests are equivalent to SKAT under particular 
kernel functions [27, 12]. For example, the C-alpha test is equivalent to SKAT using the 
kernel function K(Z i, Z i′) = Σj∈  ZijZi′j. Further, each of the burden based methods 
operate by using a univariable summary of the rare variants in  such that the outcome is a 
simple linear function of the collapsed variable Ci. Therefore, each of the CAST/CMC, 
count-based collapsing, and weighted count-based collapsing can be viewed as SKAT with a 
linear kernel constructed based on the collapsed variable. Thus we have the following tests 
and corresponding kernels:
• (Default) SKAT: K(Z i, Z i′) = Σj∈  wjZijZi′j
• C-alpha: K(Z i, Z i′) = Σj∈  ZijZi′j
• CAST (Binary Collapsing): K(Z i, Z i′) = I(Σj∈  Zij > 0)I(Σj∈  Zi′j > 0)
• Count-Based Collapsing: K(Z i, Z i′) = {Σj∈  Zij}{Σj∈  Zi′j}
• Weighted Count-Based Collapsing: K(Z i, Z i′) = {Σj∈  wjZij}{Σj∈  wjZi′j}
Given that many individual tests reduce to SKAT under different kernel, then the problem of 
choosing a particular test reduces to the problem of choosing a particular kernel.
We have, thus far, focused on testing the variants in a particular group, . In practice 
however, one must also choose, a priori, a group of variants to test. For example, one may 
apply each of the tests to all of the variants in the region or one could restrict the variants of 
interest to just the variants with <3% MAF, < 1% MAF, or <0.5% MAF, depending on how 
one wishes to define “rare”. Additionally the investigator may want to restrict to a set of 
only non-synonymous variants or those that are predicted to be “harmful” by Polyphen-2 [1] 
or other software for predicting function. Use of different choices of variants can easily be 
translated into a problem of kernel choice by simply restricting  to be different sets of 
variants. For example, we can define 3% to be the variants with MAF < 3% and 0.5% to be 
the variants with MAF < 0.5%. Then if we are interested in the C-alpha test, we can apply it 
to the variants with MAF < 3% or < 0.5% by constructing the kernels 
 and , respectively 
and test using the usual SKAT procedure. Therefore, it follows that the problem of choosing 
which group of variants to test also reduces to the problem of choosing a particular kernel.
2.2 Multi-kernel sequence kernel association test
The questions facing researchers interested in rare variant analysis are first, which is the 
most powerful test to use for a given data set, and second, which is the best group of variants 
to test within a particular region? As noted earlier, these questions can be reduced to a 
question of kernel choice: which kernel, from among a group of candidates, will yield 
highest power? Despite transforming the problem, the answer to this question requires prior 
knowledge of which variants are causal and what is their effect size and direction, 
knowledge which is rarely available (since this would preclude the need for analysis). As a 
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solution, one may choose to test under all candidate kernels and report the best p-value, but 
this clearly leads to inflated type I error. However, by exploiting the connections between 
SKAT and other tests, we can utilize a perturbation strategy, related to the approach of Wu 
et al. [26], to incorporate many tests and groupings while conserving type I error.
Our proposed unifying method, the multi-kernel SKAT (MK-SKAT), simultaneously 
considers several test and variant grouping choices at once and constructs an omnibus test. 
The idea behind the approach is that it constructs kernels based on each candidate test and 
grouping approach. For example, one may test using CAST, count-based collapsing, C-
alpha, and the default SKAT with 3 grouping strategies per test (MAF <3%, <1%, or <0.5%) 
for a total of 12 combinations corresponding then to 12 candidate kernels. MK-SKAT then 
conducts an omnibus test using a modified version of the perturbation approach of Wu et al. 
[26] to test across all of the candidate kernels. Operationally, the strategy applies SKAT 
with each of the kernels, takes the minimum p-value, and then uses perturbation based 
techniques to correct for having taking the minimum p-value. A single p-value is reported.
The intuition behind the procedure is that asymptotically σ̂−1(yi − ŷi) will be approximately 
normal such that we can replace it with a simulated normal random variable. Using the same 
simulated normals for each candidate kernel allows for capture of the correlation between 
tests. The full MK-SKAT procedure is as follows:
1. For each combination of candidate testing procedure and each candidate grouping 
procedure, construct a corresponding kernel matrix, Kℓ, to obtain a total of L 
candidate kernels.
2. Using each candidate kernel, Kℓ, obtain a corresponding score statistic as Qℓ and p-
value for significance pℓ.
3. Find the minimum p-value: pmin = min1≤ℓ≤L pℓ
4. For ℓ ∈ 1, …, L, compute Λℓ = diag(λℓ,1, …, λℓ,mℓ), and Vℓ = [vℓ,1, vℓ,2, …, vℓ,mℓ] 
where λℓ,1 ≥ λℓ,2 ≥ … ≥ λℓ,mℓ are the mℓ positive eigenvalues of  with 
corresponding eigenvectors vℓ,1, vℓ,2, …, vℓ,mℓ
5. Generate  with each .
6. For each ℓ ∈ 1, …, L, rotate r* using the eigenvectors to generate .
7. Compute  for each ℓ and obtain a corresponding p-value, , by 
comparing  to the distribution function estimated for Qℓ and obtain the upper tail 
probability exceeding . We set .
8. Repeat (5)–(7) B times to obtain  for some large number B.
9. The final p-value for significance is estimated as
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It is important to note that direct use of the p-value is necessary rather than using 
the maximum score statistic since the raw score statistics have different degrees of 
freedom.
As noted earlier, this procedure is closely related to the general perturbation procedure 
previously used for testing across multiple kernels [26]. However, some technical 
modifications have been made to tailor the procedure towards the current application. In 
particular, the previous procedure required generation of a large augmented matrix with 
dimensionality equal to the sum of the number of nonzero eigenvalues from all of the 
kernels under consideration followed by eigen decomposition of the augmented matrix. This 
can be slow if the rank of the individual kernels is high (i.e. many variants with low 
correlation) and if many kernels are under consideration (i.e. many combinations of 
groupings and possible tests); both of these can be true in rare variant studies. In contrast, 
the present strategy requires simulation of more normal random variables but bypasses the 
need for working with a large, augmented matrix.
Two key features of our test ensure that type I error is conserved despite the application of 
multiple tests and grouping. First, our test requires uninformed selection of tests and variant 
groupings. In contrast, using the data to select a single optimal test would not conserve type 
I error. Second, while it is true that the p-values of the test/grouping combinations are 
correlated, as some tests are in fact nested, our perturbation method properly captures the 
correlation and thus retains type I error control.
By capturing the correlation, our approach can accommodate a large number of tests and 
groups as a long as they are highly correlated. Perfect correlation across tests would be 
equivalent to conducting just a single test. Thus, under such scenarios, the increase in cost is 
primarily computational. If the correlation between kernels is low, there is the potential for 
larger power loss, though this is counterbalanced by the fact that one of the competing 
kernels may have much higher power. Therefore, we generally recommend inclusion of a 
broad range of tests and grouping strategies.
Although this strategy also generates a monte carlo p-value, there are two advantages in 
comparison to permutation. First, covariates and variants can be correlated. In contrast, in 
order for permutation to be valid, the variants must be uncorrelated with the covariates. 
Second, the MK-SKAT procedure is more computationally efficient since the computation 
now relies only on generating and then rotating n normal random variables while all other 
parameters remain the same. In contrast, permutation requires complete re-estimation of the 
kernel matrices, P0 matrices, eigen-decompositions, and distribution parameters.
2.3 Simulations
We conducted a series of simulations to verify that the proposed MK-SKAT procedure is 
valid in terms of controlling type I error and has reasonable power compared to the 
individual tests across which the MK-SKAT is combining.
2.3.1 Type I error—To demonstrate that the proposed methods are valid tests, in terms of 
protecting type I error, we conducted a series of simulations under null models for both 
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continuous and dichotomous traits. We used a coalescent model to simulate a region with 
100 variants in 104 haplotypes with LD structure representative of a European population 
[24]. Eighty-five of the simulated variants had a true MAF less than 3% and 80 had a MAF 
less than 1%. We then paired haplotypes to simulate n = 1,000 or 2,000 diploid individuals. 
For type I error simulations, we simulated quantitative outcomes for each individual without 
regard to the genotype values under the null model:
where Xi1 ~ ber(0.506), Xi2 ~ N(29.2, 21.1), and εi ~ N(0, 1). For dichotomous outcomes, we 
simulated n/2 cases and n/2 controls from the null logistic model:
where Xi1 ~ ber(0.506) but Xi2 ~ N(0, 1).
In total, we simulated 105 data sets as described. We applied the MK-SKAT testing 
procedure to each data set. Specifically, we considered four different testing procedures: 
CAST, count-based collapsing, the C-alpha, and SKAT tests. We also considered three 
different grouping strategies: we set the rare variant grouping, , equal to the variants with 
MAF < 0.5%, variants with MAF < 1%, and variants with MAF < 3%. Under the 
equivalence with SKAT, this yielded a total of 12 different candidate kernels. We estimated 
the type I error rate at the 0.05 level of 1) SKAT with each individual kernel, 2) MK-SKAT 
conditional on a particular testing procedure (i.e. we assumed a fixed test while considering 
multiple groupings), 3) MK-SKAT conditional on a particular grouping strategy (i.e. we 
assumed a fixed grouping while considering multiple tests), and 4) MK-SKAT testing across 
all twelve candidate kernels.
2.3.2 Power—We also assessed the power of the MK-SKAT procedure under three 
different simulation settings. For each setting, we again simulated haplotypes for a region 
containing 100 variants as in the type I error simulations. These were then paired to generate 
n = 1,000 individuals. Then we simulated outcomes under the alternative model for 
quantitative traits:
and for dichotomous traits:
Xi1, Xi2 and εi were as before, but  were the genotypes of the causal variants and β were 
the corresponding regression coefficients which varied across simulation settings. For 
dichotomous outcomes n/2 subjects were sampled as cases with the remaining n/2 set as 
controls.
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Under Setting 1, we considered a quantitative outcome with 50% of the variants with true 
population MAF < 1% randomly selected to be causal. All causal variants were given the 
same effect with β = 0.5. Since a large proportion of the variants were causal and they all 
had the same effect, this scenario favored the burden approaches and particularly count 
based collapsing.
Setting 2 again examined quantitative traits and was identical to Setting 1 except the effects 
of the causal variants were equal to −0.5 and 0.5 with equal probability. Since the causal 
variants had opposing effects, this scenario favored the similarity based tests.
Setting 3 differed from Settings 1 and 2 in that it examined the case where the outcome was 
dichotomous. Of the variants with true MAF < 3%, 20% were randomly selected to be 
causal. All causal variants were again given equal effect size of β = 0.5.
We emphasize that these simulations were not intended to serve as a comprehensive 
comparison of the methods across scenarios nor to understand when individual tests and 
grouping strategies are optimal (since this depends on the true state of nature, which is 
unknown in any real data). Instead, these simulations serve to understand how MK-SKAT 
behaves relative to the best method and grouping strategy.
3. RESULTS
3.1 Type I error and power
Type I error simulation results for quantitative traits and dichotomous traits are shown in 
Table 1 and Table 2, respectively. For quantitative traits, individual methods as well as MK-
SKAT appropriately controlled the type I error at the α = 0.05 level. However, for 
dichotomous traits, the C-alpha test and SKAT test tended to be conservative, reflecting 
previous results [27]. Thus, MK-SKAT tests were conservative as well.
Results of the power analysis for the 3 settings are shown in Tables 3 through 5. In Setting 1 
(Table 3), the count kernel applied to the variants with MAF <1% performed the best, 
followed closely by the CAST kernel applied to the same grouping. This was not surprising 
considering they were best adapted to the true model in which all effects have the same size 
and direction, and only rare variants with MAF <1% are sampled to be causative. The MK-
SKAT which tested over all 12 kernels had a power slightly less than the most powerful 
single kernel. The results of the MK-SKAT testing across all 4 tests at the 1% MAF 
threshold group showed power would be nearly equivalent to the most powerful single 
kernel as well. Also, if one tested the count kernel over the 3 groupings, power would be 
conserved.
In Setting 2, power was dramatically decreased for the count and CAST kernels compared to 
Setting 1 (Table 4). This was due to the true model having bidirectional genetic effect on the 
outcome. Some rare variants increased the outcome, while some decreased the outcome. 
Compared to Setting 1, power was reduced for C-alpha and linear weighted kernels, but not 
to the same extent as count and CAST. C-alpha and linear weighted kernels applied to the 
variants with MAF <1% performed the best in Setting 2. MK-SKAT testing over all 12 
kernels displayed power somewhat less than the most powerful single kernel, but much 
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greater than any of the CAST or count kernels. If one applied MK-SKAT over the three 
groupings of the linear weighted kernel, power would be nearly equivalent to the most 
powerful single kernel. This setting clearly showed the adaptability of the MK-SKAT 
method under variation in the genotype/phenotype structure.
Setting 3 compared power between methods for a dichotomous outcome (Table 5). The 
linear weighted kernel applied to the variants with MAF <3% performed the best. They were 
best adapted to the true model where only 20% of the variants were truly causal, and rare 
variants with MAF <3% were sampled as causative. MK-SKAT testing over all 12 kernels 
had power slightly greater than the most powerful single kernel, though this is likely to be 
within the range of monte carlo error. If one applied MK-SKAT to the three groupings using 
either the linear weighted or C-alpha kernel, power would nearly equivalent to the most 
powerful single kernel.
Overall, results show that while protecting type I error, the MK-SKAT can achieve power 
close to using the optimal test and grouping strategy. While there is generally some modest 
loss in power relative to the best choice, the proposed omnibus tests offer considerably 
better power than poor choices and represent a reasonable compromise. If one is able to 
restrict attention to a particular group of variants based on prior information or to a 
particular testing procedure based on hypotheses of the underlying model, then power can be 
further increased by restricting the MK-SKAT to fewer tests or fewer groupings.
3.2 Data analysis
We examined the performance of our proposed method on a high-depth sequence data set 
with 2,000 subjects from the CoLaus population-based collection [7]. Briefly, we examined 
a single candidate gene containing 86 variants of which the majority had allele frequency 
less than 3%. Eight variants were non-synomymous and two were predicted to be harmful. 
This gene is a drug target which has been shown to be associated with obesity and 
cardiovascular related outcomes. In addition to genotype information, we had 42 separate 
traits, most of which are related to obesity and cardiovascular measures, and additional 
demographic covariates including age, gender and the top five eigenvalues of genetic 
variability derived from the GWAS data. We illustrate the MK-SKAT procedure by 
applying it to identify which of the 42 outcome traits are associated with the rare variants 
within this candidate gene.
We specifically considered testing using CAST, count based collapsing, weighted count 
based collapsing, the C-alpha, and the default SKAT. For groupings, we considered using all 
of the variants in the region, the variants with MAF <3%, variants with MAF <1%, variants 
with MAF <0.5%, nonsynonymous variants, and variants predicted to be harmful. In total 
we considered 27 different kernels based on combinations of the test choice and grouping 
choice — the CAST, count based collapsing, and weighted count based collapsing were not 
applied to all of the variants. In addition to applying SKAT with each of the candidate 
kernels, we also applied the MK-SKAT testing across all 27 kernels.
Analysis results are presented in Figure 1, with p-values truncated at 10−6. Several p-values 
would have met the threshold for significance and will be presented elsewhere. Given that 
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the candidate gene was selected as a positive control and that many of the outcome measures 
are closely related, these results are in line with what we would anticipate. However, for the 
purposes of illustrating our methodology, the individual p-values are not particularly 
interesting. The key result is that for many traits, using different methods and different 
groupings resulted in very different results in terms of significance. MK-SKAT did not tend 
to have the smallest p-values. In general, MK-SKAT tended to yield results slightly less 
significant than those using the best kernel (choice of test and grouping strategy). However, 
MK-SKAT still performed considerably better than poor choices of kernels.
3.3 Computational run time
We examined the computational efficiency of the MK-SKAT procedure. Specifically, we 
considered the run time associated with running MK-SKAT to analyze a region with p 
observed variants in n individuals assuming that we would like to consider 12 kernels 
constructed by considering count based collapsing, weighted count based collapsing, SKAT 
and C-alpha tests with grouping thresholds of 1%, 3% and 5%. This differs slightly from the 
earlier simulations and was adjusted in order to accommodate the wider range of sample 
sizes and observed variants under consideration. However, the computational results should 
not change as the kernels and relative complexity are still the same. Results are presented in 
the left panel of Figure 2 and show that the run time increases with sample size. Although 
there are some differences in the computation time for situations with different numbers of 
variants, such were small compared to differences in run time from increased sample size. 
This is in part because the kernel machine framework requires working with n×n kernel 
matrices, irrespective of the dimensionality.
As noted earlier, the testing procedure developed in this project is based on our previous 
work [26]. However, technical adjustments were made due to improve computation within 
the context of rare variant analysis with many possible kernels. To illustrate the 
improvement in computation, we further compared the relative computational expense of the 
current MK-SKAT procedure to our previous procedure. The results are presented in the 
right panel of Figure 2 with the relative run times (run time of our current procedure divided 
by run time of the previous procedure) as a function of sample size and number of observed 
variants. When the sample size is large and when the number of variants under consideration 
increases, our current procedure can be considerably faster. On the other hand, when the 
number of variants is modest, then the previous procedure can be slightly faster though the 
difference is small.
4. DISCUSSION
In analysis of genetic rare variants, given the difficulties associated with selecting a test and 
selecting a particular group of variants to test, MK-SKAT allows investigators to 
agnostically consider several different, popular, testing approaches as well as several 
different ways of thresholding the variants. Although there is some loss of power compared 
to the best single test and best grouping, the power is still considerably higher than when 
using a poor choice of test or a poor choice of grouping strategy while still conserving type I 
error.
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Restriction of the MK-SKAT to a smaller set of possible kernels (i.e. smaller set of tests or 
groupings) can yield higher power if the considered kernels are closer to the best test and 
grouping strategy. If such information is available, such as through previous studies of 
common variants within the region or through bioinformatics knowledge, we strongly 
encourage investigators to directly restrict interest to a smaller group of candidate kernels. 
On the other hand, in the absence of reliable prior knowledge, we recommend consideration 
of a wide range of kernels. Importantly, if kernels are very similar to one another, then the 
perturbation procedure will accommodate the correlation and will not penalize the 
significance as much as if the considered kernels are more different.
We acknowledge that the computational expense of MK-SKAT can be high with larger 
sample size, making it difficult to analyze large, genome-wide sequencing studies, but a 
simple approach to decrease this burden would be to first screen using each of the candidate 
kernels individually. If none of the individual kernels are close to significance, then MK-
SKAT is unlikely to yield a significant result. Since the majority of genetic regions are not 
related to outcomes, applying MK-SKAT to only the promising genetic regions can 
considerably reduce the overall computational expense of analyzing any real experiment. 
Further computational improvements may be possible using powerful, new (i.e., parallel or 
grid) computing technologies and represent an area of future research.
Interestingly, while several methods are special cases of SKAT, some other methods are 
special cases of the MK-SKAT. The variable threshold test [23] is equivalent to MK-SKAT 
when the kernels under consideration are based on a single testing approach with only the 
variable grouping being varied. However, we note that use of perturbation still offers 
computational advantage over the threshold test. Similarly, the SKAT-O method [12] is 
equivalent to MK-SKAT in which the variable grouping is fixed but one is considering a 
range of linear combinations of SKAT and collapsing kernels. Thus, in comparison to 
SKAT-O, MK-SKAT would tend to excel when the ideal variable grouping is not chosen for 
SKAT-O. MK-SKAT buffers against a broad range of variable groupings since many can be 
tested simultaneously.
Further methods may also fall within the MK-SKAT framework, but although many popular 
tests can be considered using MK-SKAT, there are certainly many useful tests that fall 
outside. For example, tests that use the outcome information in order to estimate weights for 
variants [11, 10, 8, 14] cannot be applied. While these tests still can be considered special 
cases of SKAT, the kernel is now estimated using the outcome such that standard 
asymptotics for SKAT and the perturbation based techniques for MK-SKAT cannot be used 
to obtain p-values. Further statistical work is needed in order to allow the MK-SKAT 
procedure to encompass these methods.
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Real data analysis results. Each column of circles corresponds to the p-values from 
analyzing a different trait while each circle represents the p-value from a different kernel. 
The triangle indicates the p-value from applying MK-SKAT to all of the kernels. p-values 
have been truncated at 10−6. The dashed line indicates the bonferroni significance level.
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Computational runtime as a function of sample size for the proposed algorithm (left panel) 
and the relative computational cost of the current procedure relative to a previous procedure 
for multi-kernel testing [26] (current/previous) as a function of the number of variants and 
sample size (right panel).
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